Inventor · disambiguated record
Jin Hong
Also filed as: HONG JIN · HONG JIN SUNG
12 granted patents·19 pending applications·28 citations·filing 2005–2025
87Inventor score
Files withALIGOS THERAPEUTICS INC17JANSSEN BIOPHARMA INC5ALIOS BIOPHARMA INC4BLATT LAWRENCE M1HONG JIN1
Top patents by PatentIndex Score
31 records- 0195US12030907B2Modified nucleoside phosphoramiditesJANSSEN BIOPHARMA INC·Filed 2021·Granted Jul 9, 2024·2 cites·18 claims
- 0295US11549110B2Modified short interfering nucleic acid (siNA) molecules and uses thereofALIGOS THERAPEUTICS INC·Filed 2022·Granted Jan 10, 2023·5 cites·30 claims
- 0392US12129469B2Modified short interfering nucleic acid (siNA) molecules and uses thereofALIGOS THERAPEUTICS INC·Filed 2023·Granted Oct 29, 2024·1 cites·30 claims
- 0490US11180524B2Modified nucleoside phosphoramiditesJANSSEN BIOPHARMA INC·Filed 2018·Granted Nov 23, 2021·4 cites·24 claims
- 0588US7597884B2Hyperglycosylated polypeptide variants and methods of useALIOS BIOPHARMA INC·Filed 2006·Granted Oct 6, 2009·11 cites·27 claims
- 0687US12428441B2Modified nucleoside phosphoramiditesJANSSEN BIOPHARMA INC·Filed 2024·Granted Sep 30, 2025·0 cites·18 claims
- 0785US11166976B2S-antigen transport inhibiting oligonucleotide polymers and methodsALIGOS THERAPEUTICS INC·Filed 2020·Granted Nov 9, 2021·1 cites·6 claims
- 0884US10793859B2Modified oligonucleotides and methods of useJANSSEN BIOPHARMA INC·Filed 2017·Granted Oct 6, 2020·2 cites·10 claims
- 0983US12077757B2Modified oligonucleotides and methods of useJANSSEN BIOPHARMA INC·Filed 2020·Granted Sep 3, 2024·1 cites·15 claims
- 1081US11466274B2Modified gapmer oligonucleotides and methods of useALIGOS THERAPEUTICS INC·Filed 2020·Granted Oct 11, 2022·1 cites·16 claims
- 1181US2025092400A1Modified Oligonucleotides and Methods of UseJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 1278US2023332153A1Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses ThereofALIGOS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1376US12454691B2Modified short interfering nucleic acid (siNA) molecules and uses thereofALIGOS THERAPEUTICS INC·Filed 2022·Granted Oct 28, 2025·0 cites·29 claims
- 1470US2022364096A1Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses ThereofALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1566US2022125825A1S-antigen transport inhibiting oligonucleotide polymers and methodsALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1666US2023383296A1Modified gapmer oligomers and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1760US2011008289A1Hyperglycosylated polypeptide variants and methods of useALIOS BIOPHARMA INC·Filed 2009·Application pending·0 cites
- 1860US2010099851A1Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the sameALIOS BIOPHARMA INC·Filed 2009·Application pending·0 cites
- 1959US2022160748A1Conjugates of s-antigen transport inhibiting oligonucleotide polymers having enhanced liver targetingALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2057US8372964B2Highly infectious nucleic acid molecules from pepper mottle virus and plant viral vector derived from the sameSEOUL WOMENS UNIV INDUSTRY UNIV COOPERATION FOUNDATION·Filed 2008·Granted Feb 12, 2013·0 cites·6 claims
- 2157US2025382618A1Methods and compositions for inhibiting virusALIGOS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2255US2021189392A1S-antigen transport inhibiting oligonucleotide polymers and methodsALIGOS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2355US2021317457A1Antisense oligonucleotide (aso) molecules and uses thereof for coronavirus diseasesALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2455US2022380770A1SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES AND USES THEREOF FOR CORONAVIRUS DISEASESALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2552US2025368996A1Modified antisense oligonucleotides for treating hepatitis b virusALIGOS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2652US2022056451A1Hbv binding oligonucleotides and methods of useALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2749US2020147124A1S-antigen transport inhibiting oligonucleotide polymers and methodsALIGOS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2849US2006018875A1Interferon compositions and methods of use thereofBLATT LAWRENCE M·Filed 2005·Application pending·0 cites
- 2948US2009220943A1Hcv genotyping and phenotypingINTERMUNE INC·Filed 2008·Application pending·0 cites
- 3047US2006182716A1Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the sameHONG JIN·Filed 2006·Application pending·0 cites
- 3142US2018179542A1OLIGONUCLEOTIDE TARGETING STRATEGY FOR cccDNAALIOS BIOPHARMA INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jin Hong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →